Regulatory Toxicology And Pharmacology

Regulatory Toxicology And Pharmacology英文簡(jiǎn)介

Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.

Types of peer-reviewed articles published:

-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:

1.Factors influencing human sensitivity

2.Exposure science related to risk assessment

3.Alternative toxicological test methods

4.Frameworks for evaluation and integration of data in regulatory evaluations

5.Harmonization across regulatory agencies

6.Read-across methods and evaluations

-Contemporary Reviews on policy related Research issues

-Letters to the Editor

-Guest Editorials (by Invitation)

Regulatory Toxicology And Pharmacology中文簡(jiǎn)介

《Regulatory Toxicology And Pharmacology》是一本由ACADEMIC PRESS INC ELSEVIER SCIENCE出版商出版的專(zhuān)業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于1981年，刊期Monthly，該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCI、SCIE收錄。在中科院最新升級(jí)版分區(qū)表中，該刊分區(qū)信息為大類(lèi)學(xué)科：醫(yī)學(xué) 3區(qū)，小類(lèi)學(xué)科：醫(yī)學(xué)：法 3區(qū)；藥學(xué) 3區(qū)；毒理學(xué) 3區(qū)；在JCR（Journal Citation Reports）分區(qū)等級(jí)為Q1。該刊發(fā)文范圍涵蓋醫(yī)學(xué)：法等領(lǐng)域，旨在及時(shí)、準(zhǔn)確、全面地報(bào)道國(guó)內(nèi)外醫(yī)學(xué)：法工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動(dòng)態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵(lì)學(xué)術(shù)創(chuàng)新。2021年影響因子為3.598，平均審稿速度平均3月。

中科院分區(qū)最新升級(jí)版（當(dāng)前數(shù)據(jù)版本：2021年12月最新升級(jí)版）

大類(lèi)學(xué)科	分區(qū)	小類(lèi)學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	4區(qū)	MEDICINE, LEGAL 醫(yī)學(xué)：法 PHARMACOLOGY & PHARMACY 藥學(xué) TOXICOLOGY 毒理學(xué)	3區(qū) 4區(qū) 4區(qū)	否	否

JCR分區(qū)（當(dāng)前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級(jí)	JCR所屬學(xué)科	分區(qū)	影響因子
Q1	MEDICINE, LEGAL	Q1	3.598
	TOXICOLOGY	Q2
	PHARMACOLOGY & PHARMACY	Q2

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類(lèi)文章占比	OA開(kāi)放訪(fǎng)問(wèn)	平均審稿速度
3.598	90	33.51%	86.52%	未開(kāi)放	平均3月

IF值(影響因子)趨勢(shì)圖